KSWA
ABBV icon

Kathleen S. Wright Associates’s AbbVie ABBV Stock Holding History

Kathleen S. Wright Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$53.7K Hold
232
– – 0.02% 145
2025
Q2 		$43.1K Hold
232
– – 0.02% 155
2025
Q1 		$48.6K Hold
232
– – 0.02% 147
2024
Q4 		$41.2K Hold
232
– – 0.02% 157
2024
Q3 		$45.8K Buy
+232
New +$43.3K 0.02% 154

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kathleen S. Wright Associates's ABBV Position: Q3 2025 in Review

Kathleen S. Wright Associates held its AbbVie (ABBV) position steady in Q3 2025 at 232 shares worth $53.7K. The position accounts for 0.02% of the portfolio, ranked #145.

Kathleen S. Wright Associates first reported a position in ABBV in Q3 2024 and has held it in 5 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Kathleen S. Wright Associates held 232 shares of AbbVie worth $53.7K as of Q3 2025.
  • Kathleen S. Wright Associates left its AbbVie share count unchanged in Q3 2025.
  • AbbVie made up 0.02% of Kathleen S. Wright Associates's portfolio in Q3 2025, its #145 holding.
  • Kathleen S. Wright Associates first reported a position in AbbVie in Q3 2024 and has held it in 5 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Kathleen S. Wright Associates's 13F filing for Q3 2025, filed 10 Oct 2025.